Calibration of AlgoRithm for Detection of Cardiac Decompensation Via Parametric Objects (CARDCOP)
CARDCOP
1 other identifier
observational
640
1 country
3
Brief Summary
The goal of the study is to calibrate the algorithmic model of the TakeCoeur AI device to detect early heart failure decompensation in patients with heart failure, using physiological data (clinical) actively and passively collected through connected medical devices (watch, blood pressure monitor, and scale).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedOctober 28, 2024
October 1, 2024
1 year
September 30, 2024
October 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Concordance between the detection of heart failure decompensation by the TakeCoeur AI device and the occurrence of heart failure decompensation
calibrate the algorithmic model of the TakeCoeur IA device for early detection of cardiac decompensation in patients suffering from heart failure.
From enrollment to the end of the 6-month follow-up period.
Secondary Outcomes (2)
Evaluate the time (in days) to anticipate cardiac decompensation
From enrollment to the end of the 6-month follow-up period.
Evaluate the compliance of patients with heart failure to the Takecoeur IA device and its connected collection accessories
From enrollment to the end of the 6-month follow-up period.
Eligibility Criteria
Participation in the study will be offered to any patient consulting a cardiologist/cardio-geriatrician at one of the participating centers who meets the inclusion criteria and non inclusion criteria.
You may qualify if:
- Age ≥ 18 years
- Patient diagnosed with chronic heart failure, confirmed by a cardiologist/cardio-geriatrician (regardless of the type and etiology of the disease), meeting at least one of the following two conditions:
- Hospitalization in the past 12 months for a heart failure exacerbation.
- French speaking patient
- Patient equipped with a smartphone, computer, or tablet with internet/cellular access (of with the help of a caregiver)
- Patient affiliated with a social security scheme
You may not qualify if:
- Patient undergoing dialysis for renal failure
- Patient who has received or is scheduled to receive a heart transplant or circulatory assistance within the next 12 months
- Patient with a left ventricular ejection fraction ≥ 50% (for non-diastolic heart failure)
- Obese patient with a body mass index ≥ 40 kg/m²
- Patient with severe aortic stenosis who is contraindicated for surgery or TAVI
- Patient with a life expectancy of \< 1 year due to a condition other than heart failure (cancer, cirrhosis, respiratory failure, etc.)
- Patient already benefiting from a telemonitoring device
- Physical or psychological inability (dementia, schizophrenia, substance-related disorder) of the patient or caregiver to use the digital data collection device, as judged by the physician
- Patient refusal to allow the transmission of the data necessary for monitoring the effective use of the device and obtaining individualized or national real-world usage results
- Patient under guardianship, curatorship, or any other administrative or judicial measure restricting rights and freedoms
- Patient unable to wear the watch for the duration of the study due to skin conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Chu Brest
Brest, 29609, France
CH Morlaix
Morlaix, 29600, France
CH Vannes
Vannes, 56000, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2024
First Posted
October 28, 2024
Study Start
November 1, 2024
Primary Completion
November 1, 2025
Study Completion
May 1, 2026
Last Updated
October 28, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning three years and ending fifteen years following the final study report completion
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
All collected data that underlie results in a publication